Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P41181 (
collecting duct
)
5,183
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Collectrin
, a novel homolog of angiotensin-converting enzyme-related carboxypeptidase (ACE2), was identified during polymerase chain reaction-based cDNA subtraction and up-regulated in 5/6 ablated kidneys at hypertrophic phase.
Collectrin
, with 222 amino acids, has an apparent signal peptide and a transmembrane domain; the sequence is conserved in mouse, rat, and human and shares 81.9% identity. Human
collectrin
has 47.8% identity with non-catalytic extracellular, transmembrane, and cytosolic domains of ACE2; however, unlike ACE and ACE2,
collectrin
lacks active dipeptidyl carboxypeptidase catalytic domains. The
collectrin
mRNA transcripts are expressed exclusively in the kidney. In situ hybridization reveals its mRNA expression in renal collecting ducts, and immunohistochemistry shows that it is localized to the luminal surface and cytoplasm of collecting ducts. Immunoprecipitation studies, using [35S]methionine-labeled renal cortical and inner medullar
collecting duct
cells, i.e. M-1 and mIMCD-3, indicate that the protein size is approximately 32 kDa. During the development of mouse kidney, mRNA signal is detectable at day 13 of gestation, and the protein product is observed in the ureteric bud branches. Its expression is progressively increased during later stages of the gestation extending into the neonatal periods and then is decreased in adult life. Up-regulated expression of
collectrin
in the hypertrophic kidneys after renal ablation and restricted spatio-temporal expression during development indicates a possible role(s)in the process of progressive renal failure and renal organogenesis.
...
PMID:Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. 1127 14
Collectrin
, a homologue of angiotensin converting enzyme 2 (ACE2), is a type I transmembrane protein, and we originally reported its localization to the cytoplasm and apical membrane of
collecting duct
cells. Recently, two independent studies of targeted disruption of
collectrin
in mice resulted in severe and general defects in renal amino acid uptake.
Collectrin
has been reported to be under the transcriptional regulation by HNF-1alpha, which is exclusively expressed in proximal tubules and localized at the luminal side of brush border membranes. The deficiency of
collectrin
was associated with reduction of multiple amino acid transporters on luminal membranes. In the current study, we describe that
collectrin
is a target of HNF-1beta and heavily expressed in the primary cilium of renal
collecting duct
cells.
Collectrin
is also localized in the vesicles near the peri-basal body region and binds to gamma-actin-myosin II-A, SNARE, and polycystin-2-polaris complexes, and all of these are involved in intracellular and ciliary movement of vesicles and membrane proteins. Treatment of mIMCD3 cells with
collectrin
siRNA resulted in defective cilium formation, increased cell proliferation and apoptosis, and disappearance of polycystin-2 in the primary cilium. Suppression of
collectrin
mRNA in metanephric culture resulted in the formation of multiple longitudinal cysts in ureteric bud branches. Taken together, the cystic change and formation of defective cilium with the interference in the
collectrin
functions would suggest that it is necessary for recycling of the primary cilia-specific membrane proteins, the maintenance of the primary cilia and cell polarity of
collecting duct
cells. The transcriptional hierarchy between HNF-1beta and PKD (polycystic kidney disease) genes expressed in the primary cilia of
collecting duct
cells has been suggested, and
collectrin
is one of such HNF-1beta regulated genes.
...
PMID:The role for HNF-1beta-targeted collectrin in maintenance of primary cilia and cell polarity in collecting duct cells. 1747 36
Collectrin
(Tmem27) is a transmembrane glycoprotein that is highly expressed in the kidney and vascular endothelium. It is a homologue of the angiotensin-converting enzyme 2 (ACE2) but harbors no catalytic domain. In the extravascular tissues of the kidney,
collectrin
is localized to the proximal tubule and
collecting duct
.
Collectrin
-deficient mice are featured with hypertension and exaggerated salt sensitivity. These phenotypes are associated with impaired uptake of the nitric oxide precursor L-arginine and the expression of its amino acid transporters, CAT-1 and y(+)LAT1, in endothelial cells. In addition,
collectrin
-deficient mice display decreased dimerization of nitric oxide synthase and decreased nitric oxide synthesis, but enhanced superoxide generation, suggesting that deletion of
collectrin
leads to a state of nitric oxide synthase uncoupling. These findings suggest that
collectrin
plays a protective role against hypertension. The
collectrin
knockout mouse represents a unique model for hypertension research. Furthermore,
collectrin
may serve as a novel therapeutic target in the treatment of hypertension.
...
PMID:Role of collectrin, an ACE2 homologue, in blood pressure homeostasis. 2518 62
Collectrin
, encoded by the
Tmem27
gene, is a transmembrane glycoprotein with approximately 50% homology with angiotensin converting enzyme 2, but without a catalytic domain.
Collectrin
is most abundantly expressed in the kidney proximal tubule and
collecting duct
epithelia, where it has an important role in amino acid transport.
Collectrin
is also expressed in endothelial cells throughout the vasculature, where it regulates L-arginine uptake. We previously reported that global deletion of
collectrin
leads to endothelial dysfunction, augmented salt sensitivity, and hypertension. Here, we performed kidney crosstransplants between wild-type (WT) and
collectrin
knockout (
Tmem27
Y/-
) mice to delineate the specific contribution of renal versus extrarenal
collectrin
on BP regulation and salt sensitivity. On a high-salt diet, WT mice with
Tmem27
Y/-
kidneys had the highest systolic BP and were the only group to exhibit glomerular mesangial hypercellularity. Additional studies showed that, on a high-salt diet,
Tmem27
Y/-
mice had lower renal blood flow, higher abundance of renal sodium-hydrogen antiporter 3, and lower lithium clearance than WT mice. In WT mice, administration of angiotensin II for 2 weeks downregulated
collectrin
expression in a type 1 angiotensin II receptor-dependent manner. This downregulation coincided with the onset of hypertension, such that WT and
Tmem27
Y/-
mice had similar levels of hypertension after 2 weeks of angiotensin II administration. Altogether, these data suggest that salt sensitivity is determined by intrarenal
collectrin
, and increasing the abundance or activity of
collectrin
may have therapeutic benefits in the treatment of hypertension and salt sensitivity.
...
PMID:Renal Collectrin Protects against Salt-Sensitive Hypertension and Is Downregulated by Angiotensin II. 2806 68